-
Mashup Score: 0
A cardiopulmonary MRI conducted during unsedated sleep aided in early detection of pulmonary vascular disease in preterm infants with bronchopulmonary dysplasia, according to results published in European Respiratory Journal.“As pulmonary vascular disease (PVD) significantly determines long-term morbidity and mortality, mainly through its later, often undetected progression into [pulmonary
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Respiratory Outcomes for Ventilator-Dependent Children With Bronchopulmonary Dysplasia - 12 month(s) ago
OBJECTIVES. To describe outpatient respiratory outcomes and center-level variability among children with severe bronchopulmonary dysplasia (BPD) who require tracheostomy and long-term mechanical ventilation.METHODS. Retrospective cohort of subjects with severe BPD, born between 2016 and 2021, who received tracheostomy and were discharged on home ventilator support from 12 tertiary care centers…
Source: American Academy of PediatricsCategories: Latest Headlines, PulmonologyTweet-
#Respiratory Outcomes for #Ventilator-Dependent #Children With #Bronchopulmonary #Dysplasia https://t.co/f2TWSdlvKL https://t.co/rXY7FpKNPM
-
-
Mashup Score: 1Allergic Bronchopulmonary Aspergillosis in Identical Twins: Effectiveness of Dupilumab - 1 year(s) ago
Article infoPublication historyAccepted: December 29, 2022Received in revised form: December 28, 2022Received: September 21, 2022Publication stageIn Press Journal Pre-ProofFootnotesEmail addresses:PAL: [email protected]MR: [email protected]NS: [email protected]FCF: [email protected]AS: [email protected]JP:…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Allergic #Bronchopulmonary #Aspergillosis in Identical #Twins: Effectiveness of #Dupilumab https://t.co/fdXlpDHKG8
-
-
Mashup Score: 1Defining the Outcome Markers and Therapeutic Role for Omalizumab in Treatment of Allergic Bronchopulmonary Aspergillosis - 1 year(s) ago
Because other biologics had not proved effective, it was a milestone when omalizumab was approved for treatment of moderate to severe allergic asthma in Australia in 2002, the United States 2003, and the European Union in 2005. By 2016, there was U.S. Food and Drug Administration approval for administration of omalizumab for asthma for children ages 6 to 11. The primary outcome marker from…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press (FREE)! Defining the Outcome #Markers and #Therapeutic Role for #Omalizumab in #Treatment of #Allergic #Bronchopulmonary #Aspergillosis https://t.co/zy4Of3Gy3K
-
-
Mashup Score: 3Omalizumab in allergic bronchopulmonary aspergillosis (ABPA): A systematic review and meta-analysis - 1 year(s) ago
An unmet clinical need exists in the management of treatment-refractory allergic bronchopulmonary aspergillosis (ABPA). Omalizumab has shown promising effects in case series and cohort studies; however, evidence to support its routine clinical use is lacking.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Omalizumab in #allergic #bronchopulmonary #aspergillosis (ABPA): A systematic #review and meta- #analysis https://t.co/h8dHPtRjCC https://t.co/6IomdyVeoY
-
-
Mashup Score: 0Daycare Attendance is linked to Increased Risk of Respiratory Morbidities in Preterm Children with Bronchopulmonary Dysplasia - PubMed - 2 year(s) ago
In this study, preterm children with BPD who attend daycare were more likely to visit the emergency department, use systemic steroids and have chronic respiratory symptoms compared with children not in daycare indicating that daycare may be a potential modifiable risk factor to minimize respiratory …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
Daycare Attendance is linked to Increased Risk of #Respiratory #Morbidities in #Preterm #Children with #Bronchopulmonary #Dysplasia https://t.co/zlmThbHxTE https://t.co/5mOjlb7xGr
-
-
Mashup Score: 0Insurance Coverage and Respiratory Morbidities in Bronchopulmonary Dysplasia - PubMed - 2 year(s) ago
Children with BPD who received Medicaid coverage were more likely to utilize acute care and have nighttime respiratory symptoms during the first three years of life. More comprehensive studies are needed to determine why whether use of Medicaid represents a population with barriers to accessing care …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
#Insurance #Coverage and #Respiratory #Morbidities in #Bronchopulmonary #Dysplasia https://t.co/E4mQqsFcRL https://t.co/TaGLKJ6Viv
-
-
Mashup Score: 0Reply to “Current approach to the diagnosis of allergic bronchopulmonary aspergillosis” - 3 year(s) ago
We thank TĂĽrk et al1 for the interest shown in our article.2 Regarding their first question, the prevalence of allergic bronchopulmonary aspergillosis (ABPA) in our study was 19.6% (106 of 542) as assessed by a multidisciplinary team (MDT). We classified our asthmatic subjects as mild-to-moderate (mild intermittent, mild persistent, and moderate persistent) and severe (comprising severe…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Reply to “Current approach to the #diagnosis of #allergic #bronchopulmonary #aspergillosis” https://t.co/hMqvwSNUFH
-
-
Mashup Score: 0
We read the work of Saxena et al1 with great interest. In this study, the authors aimed to compare the diagnostic performance of various criteria used for evaluating allergic bronchopulmonary aspergillosis (ABPA) and found that the International Society for Human and Animal Mycology (ISHAM) criteria were only marginally better than the Rosenberg-Patterson criteria to identify ABPA in patients…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Current approach to the diagnosis of #allergic #bronchopulmonary #aspergillosis https://t.co/saNwjTOt0S
-
-
Mashup Score: 0Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-Analysis - 3 year(s) ago
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus fumigatus and impacts 10% of individuals with cystic fibrosis (CF). A diagnosis of ABPA is challenging to establish in CF owing to overlapping clinical and radiologic features with CF lung disease. Recent studies have identified blood tests, imaging, and other biomarkers that may be useful for diagnosis.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Biomarkers for the Diagnosis of #Allergic #Bronchopulmonary #Aspergillosis in #Cystic #Fibrosis: A Systematic Review and Meta-Analysis https://t.co/o9cGYsJRkh https://t.co/G7IUwZWwoe
-
🔑 takeaways from @ERSpublications: 👉Evaluating pulmonary artery flow and cardiac function with #MRI revealed parameters that detect #bronchopulmonary #dysplasia-related pulmonary vascular disease. 👉This method does not require sedation of #infants. https://t.co/YOP8dZIObV